Here, it is shown that activation of tumor cell‐intrinsic cyclin D1‐CDK4/6 signaling is associated with low tumor‐infiltrating lymphocyte populations and immunotherapy resistance in head and neck squamous cell carcinoma (HNSCC). This evidence concerns the gene CDK4 and neoplasm.